Outcome of first-episode schizophrenia in India: longitudinal study of effect of insight and psychopathology

被引:74
|
作者
Saravanan, Balasubramanian [2 ]
Jacob, K. S. [2 ]
Johnson, Shanthi [2 ]
Prince, Martin
Bhugra, Dinesh
David, Anthony S. [1 ]
机构
[1] Kings Coll London, Inst Psychiat, Sect Cognit Neuropsychiat, London SE5 8AF, England
[2] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India
基金
英国惠康基金;
关键词
D O I
10.1192/bjp.bp.109.068577
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Transcultural studies have found lack of insight to be an almost invariable feature of acute and chronic schizophrenia, but its influence on prognosis is unclear. Aims To investigate the relationship between insight, psychopathology and outcome of first-episode schizophrenia in Vellore, India. Method Patients with a DSM-IV diagnosis of schizophrenia (n = 131) were assessed prospectively at baseline and at 6-month and 12-month follow-up. Demographic and clinical measures included insight, psychopathology, duration of untreated psychosis (DUP) and social functioning. Linear and logistic regression was used to measure predictors of outcome. Results Follow-up data were available for 115 patients at 1 year. All achieved remission, half of them with and half without residual symptoms. Changes in psychopathology and insight during the first 6 months and DUP strongly predicted outcome (relapse or functional impairment), controlling for baseline measures. Conclusions Outcome of schizophrenia in this setting is driven by early symptomatic improvement and is relatively favourable, in line with other studies from low- and middle-income countries. Early improvement in insight might be a useful clinical guide to future outcome. Reduction of DUP should be a target for intervention.
引用
收藏
页码:454 / 459
页数:6
相关论文
共 50 条
  • [21] Prefrontal subregions and dimensions of insight in first-episode schizophrenia - A pilot study
    Shad, MU
    Muddasani, S
    Keshavan, MS
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2006, 146 (01) : 35 - 42
  • [22] Depressive symptoms and outcome in first-episode schizophrenia
    Radomsky, ED
    Keshavan, MS
    Haas, GL
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 29 - 30
  • [23] INSIGHT INTO DEFICITS? THE DEFICIT SYNDROME IN FIRST-EPISODE SCHIZOPHRENIA
    Trotman, Hanan D.
    Compton, M. T.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 15 - 15
  • [24] Insight, treatment outcomes and recovery in first-episode schizophrenia
    Agid, O.
    Siu, C. O.
    Harvey, P. D.
    Zipursky, R. B.
    Remington, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S449 - S449
  • [25] TREATMENT OUTCOMES, INSIGHT AND RECOVERY IN FIRST-EPISODE SCHIZOPHRENIA
    Agid, Ofer
    Siu, Cynthia
    Harvey, Philip D.
    Zipursky, Robert
    Fervaha, Gagan
    Foussias, George
    McDonald, Krysta
    Remington, Gary
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S165 - S166
  • [26] Clinical and cognitive correlates of insight in first-episode schizophrenia
    Chan, Sherry K. W.
    Chan, Kevin K. S.
    Lam, May M. L.
    Chiu, Cindy P. Y.
    Hui, Christy L. M.
    Wong, Gloria H. Y.
    Chang, W. C.
    Chen, Eric Y. H.
    SCHIZOPHRENIA RESEARCH, 2012, 135 (1-3) : 40 - 45
  • [27] A longitudinal study of cognitive insight and cortical thickness in first-episode psychosis
    Buchy, Lisa
    Makowski, Carolina
    Malla, Ashok
    Joober, Ridha
    Lepage, Martin
    SCHIZOPHRENIA RESEARCH, 2018, 193 : 251 - 260
  • [28] Profile analysis of cognitive function in first-episode schizophrenia: A longitudinal study
    Schuepbach, D
    Keshavan, MS
    Sweeney, JA
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 15S - 16S
  • [29] Longitudinal MRI study of the midline brain regions in first-episode schizophrenia
    Takahashi, Tsutomu
    Nakamura, Kazue
    Ikeda, Eiji
    Furuichi, Atsushi
    Kido, Mikio
    Nakamura, Yumiko
    Kawasaki, Yasuhiro
    Noguchi, Kyo
    Seto, Hikaru
    Suzuki, Michio
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2013, 212 (02) : 150 - 153
  • [30] Longitudinal proton magnetic resonance spectroscopy study in first-episode schizophrenia
    Galinska-Skok, B.
    Szulc, A.
    Tarasow, E.
    Kubas, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S457 - S458